Mar 17, 2011

User-Friendly Postpartum Hemorrhage Drug Could Help Lower Maternal Mortality


Postpartum Hemorrhage is the main cause of maternal mortality in developing countries. A class of drugs called oxytocics cause contraction of the uterus and the ejection of the placenta, decreasing blood loss for pregnant women in labor (which results in reduced deaths). The drugs that are typically used to prevent postpartum haemorrhage are oxytocin and ergometrine. Both of these drugs must be refrigerated and injected in order to be effective. But now an alternative drug - Misoprostol - is available, which does not require refrigeration and can be taken orally. If used correctly, Misoprostol could reduce maternal mortality caused by postpartum hemorrhage without the other requirements of oxytocics, making it more user-friendly and a much better option for the developing world, where refrigeration is not always reliable due to power outages and health care facilities often lack vital supplies. 

We at Life for Mothers (LfM) are enthusiastic about the possibility of training community health workers to use misoprostol when needed. This is part and parcel of our holistic strategy to reduce maternal mortality. Click here to read full article:

Did you know?

Women in developing countries are 300 times more likely to die than those in the industrialized world.

Source:UNICEF, 2010

Franck Muller USA
is a proud sponsor of